SauveBio
SauveBio is a Worcester, Massachusetts-based contract research organization founded in 2024 that provides flow cytometry, cell sorting, and biomedical laboratory support services to research clients. The company operates as a small (1-10 employee) private CRO with a co-founder-led leadership team.
- Company typePrivate
- Founded2024
- HeadquartersWorcester, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What SauveBio does
SauveBio is a privately held, for-profit contract research organization founded in 2024 and headquartered in Worcester, Massachusetts. The company specializes in flow cytometry, cell sorting, and biomedical laboratory support services, targeting research-oriented clients — likely academic labs, biotech startups, and pharmaceutical R&D groups — that require specialized cell-analysis capabilities outside their own infrastructure. The operating model is service-based: revenue is generated through project contracts, assay work, or hourly lab-services billing typical of small CROs, though no pricing, customer, or contract data are publicly disclosed.
The technical scope is centered on flow cytometry instrumentation and cell-sorting workflows rather than software, devices, or proprietary reagents. No information is available regarding equipment models, throughput capacity, assay menu, proprietary methods, or certifications (e.g., CLIA, GLP, ISO), which limits assessment of technical differentiation. The firm's web presence is currently a placeholder/verification page, indicating that public-facing marketing, scientific content, and client onboarding materials have not yet been published.
SauveBio is in an early-stage operating posture: 1-10 employees, no disclosed funding rounds, no announced partnerships, and no customer references. The leadership team comprises co-founders Hannah Sheehan (CEO, Co-Founder & CSO) and Jeffrey Sauve (President, Co-Founder & CFO), with Paul Wengender serving as Chief Commercial Officer, covering scientific, financial, and commercial functions. Given the recency of founding and the absence of disclosed financial, commercial, or technical details, the company should be evaluated as a nascent CRO whose commercial trajectory is yet to be evidenced.
SauveBio firmographics
Firmographics- Name
- SauveBio
- Website
- https://sauvebio.com
- Company type
- Private
- Founded year
- 2024
- Headcount range
- 1–10 employees
- Short description
- SauveBio is a Worcester, Massachusetts-based contract research organization founded in 2024 that provides flow cytometry, cell sorting, and biomedical laboratory support services to research clients. The company operates as a small (1-10 employee) private CRO with a co-founder-led leadership team.
- Ownership category
- akta.pro rank
SauveBio industry classification
Industry- Product category
- Contract Research Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE)
- akta.pro secondary industries
- Clinical CROs (Phase I–IV) (HLAGAAAA), Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)
Keywords
Where SauveBio is headquartered
LocationHeadquarters
- HQ city
- Worcester
- HQ country
- United States
- HQ region
- North America
Markets served
SauveBio business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
SauveBio product offering
Product offeringCore offering
SauveBio is a contract research organization (CRO) that provides specialized flow cytometry, cell sorting, and biomedical laboratory support services to research clients. The firm supports academic, biotech, and pharmaceutical researchers who need expert cell analysis and separation capabilities delivered on a fee-for-service basis.
Differentiator
Problem solved
Functional benefit
Products and services
- Flow cytometry services
- Cell sorting services
- Biomedical laboratory support services
Companies that use SauveBio
Customer profileIdeal customer profiles1 record
SauveBio technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
SauveBio partnerships and signals
Strategic signalRecent moves3 records
Expansion highlights2 records
SauveBio competitors and assessment
Company assessmentDirect peers
- Cell Signaling Technology: Provider of flow cytometry antibodies, reagents, and supporting services for cell biology and translational research, with growing presence in cell therapy and immuno-oncology. Comparable as a specialized provider of cytometry-related products and services.
- Beckman Coulter Life Sciences: Major instrument and reagent vendor for flow cytometry and cell sorting, with associated service and analysis offerings (e.g., Cytobank). Competes both as a tools vendor and as a service provider for cytometry-based clinical and research work.
- Q² Solutions: Joint venture between IQVIA and Quest Diagnostics operating central and specialty clinical trial laboratories, including flow cytometry services for pharma and biotech sponsors. Q² Solutions is the closest scaled comparable to SauveBio's positioning as a clinical trial lab services CRO.
Broad incumbents
- WuXi AppTec: Global CRO/CDMO offering discovery, preclinical, and central lab services with significant cell-based assay and cytometry capability. A scaled international competitor for outsourced lab services work.
- Charles River Laboratories: Major CRO with discovery, safety assessment, and central lab services, including flow cytometry-enabled preclinical and translational work. Competes for cell therapy and immuno-oncology lab services contracts.
- Labcorp Drug Development (Fortrea): Spin-out of Labcorp's clinical development business providing central lab and clinical trial services globally, including flow cytometry and biomarker testing. A scaled incumbent competing for the same CRO lab services budget.
- Eurofins Scientific: Global lab services group with significant central lab and specialty testing operations serving pharma sponsors, including flow cytometry and cell-based assay work. Operates broadly across life sciences testing and competes for the same outsourced lab services that SauveBio targets.
- BD Biosciences: Dominant flow cytometry instrument and reagent vendor (including FlowJo analysis software) and operator of a clinical trial flow cytometry services business via BD's biosciences division. Competes for both instrument and outsourced cytometry service spend.
Emerging players
- Omiq: Cloud-based cytometry analysis platform serving translational and clinical researchers, including cell therapy workflows. Comparable as a specialized enabler of flow cytometry work and a potential partner or competitor depending on SauveBio's service mix.
- FlowJo / Becton Dickinson: Specialty analysis platform for flow cytometry data with associated services used by clinical and translational researchers. Adjacent to SauveBio's offering as the data analysis layer over cytometry work.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat1 record
Key risks5 records
Key highlights4 records
Customer concentration
SauveBio social profiles
Digital presenceSauveBio financial estimates
Financial estimateRevenue estimate
Valuation estimate
SauveBio leadership team
Management profileNumber of profiles
Profiles3 records
SauveBio funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SauveBio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SauveBio
What does SauveBio do?
SauveBio is a contract research organization (CRO) that provides specialized flow cytometry, cell sorting, and biomedical laboratory support services to research clients. The firm supports academic, biotech, and pharmaceutical researchers who need expert cell analysis and separation capabilities delivered on a fee-for-service basis.
When was SauveBio founded?
SauveBio was founded in 2024. It employs 1 to 10 people.
Where is SauveBio based?
SauveBio is headquartered in Worcester, United States, in the North America region.
Who are SauveBio's main competitors?
Direct peers on record are Cell Signaling Technology, Beckman Coulter Life Sciences and Q² Solutions. Broad incumbents are WuXi AppTec, Charles River Laboratories, Labcorp Drug Development (Fortrea), Eurofins Scientific and BD Biosciences. Emerging players are Omiq and FlowJo / Becton Dickinson.
Does SauveBio have an API?
No public API is recorded for SauveBio.
What industry is SauveBio in?
SauveBio's product category is Contract Research Services. Its primary akta.pro industry code is HLAGAAAE, Central Laboratory & Clinical Trial Testing CROs, with a secondary code of HLAGAAAA, Clinical CROs (Phase I–IV). Its NAICS code is 54171 and its SIC code is 8071.